After confirming that JCPyV VLP-SPBs can bind specifically to bladder cancer cells, we further tested whether JCPyV VLPs conjugated with SPB could selectively deliver the suicide gene tk to inhibit bladder cancer cell growth in the presence of ganciclovir (GCV). The gene discussed is TKT; the disease is urinary bladder carcinoma.